Dystrogen Therapeutics S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Pharmaceutical Preparation Manufacturing | Other Information Services | Engineering Services | Computer Systems Design and Related Services | Administrative Management and General Management Consulting Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services

Full name: Dystrogen Therapeutics S.A.

Profile Updated: November 30, 2023

Dystrogen Therapeutics S.A. is an enterprise located in Poland, with the main office in Poznan. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was first established on February 19, 2018.

Headquarters
Ul. Kasztelanska 49
Poznan; Wielkopolskie; Postal Code: 60-316

Contact Details: Purchase the Dystrogen Therapeutics S.A. report to view the information.

Website: http:// dystrogen.com

Basic Information

Registered Capital:

Purchase the Dystrogen Therapeutics S.A. report to view the information.

Financial Auditors:

Purchase the Dystrogen Therapeutics S.A. report to view the information.

Incorporation Date:

February 19, 2018

Key Executives

Purchase this report to view the information.

Supervisory Authority

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Similar companies